1) Heparin calcium
肝素钙
1.
Exploration of heparin calcium for expressions of matrix metalloproteinases in glomeruli;
肝素钙对肾小球内基质金属蛋白酶表达作用的探讨
2.
Objective To evaluate the therapeutical effect of low molecular heparin calcium in the prevention of Henoch-Schonlein purpura nephritis(HSPN).
目的观察低分子肝素钙在预防小儿过敏性紫癜肾损害中的作用。
2) Hepacarin
肝素钙
1.
Therapeutic effects of Hepacarin in IgA Nephropathy;
肝素钙治疗IgA肾病临床分析
2.
Therapeutic Effect of Low-Dose Hepacarin in the Childhood Primary Nephrotic Syndrome;
小剂量肝素钙治疗小儿原发性肾病综合征疗效评价
3) nadroparin calcium
那曲肝素钙
1.
Effect of nadroparin calcium and simvastatin on patients with unstable angina peetoris;
那曲肝素钙和辛伐他汀联用治疗不稳定心绞痛临床观察
4) nadroparin calcium
那屈肝素钙
1.
Effect of nadroparin calcium on blood rheology and cerebral blood flow in acute cerebral infarction patients;
那屈肝素钙对急性脑梗死病人血液流变学和脑血流量的影响
2.
AIM: To observe the effects of nadroparin calcium on patients with acute cerebral infarction in different course of disease.
目的 :研究那屈肝素钙治疗不同发病时间脑梗死的疗效。
5) Low molecular weight heparin calcium
低分子量肝素钙
1.
Study on the oral preparation of low molecular weight heparin calcium;
低分子量肝素钙口服制剂的研究
6) low molecular weight heparin calcium
低分子肝素钙
1.
Evaluate the efficacy of a combination of Honghua injection with low molecular weight heparin calcium on cerebral infarction;
红花注射液与低分子肝素钙联合治疗脑梗死疗效分析及观察
2.
The clinical observation of low molecular weight heparin calcium in treating the patients with acute cerebral infarction;
低分子肝素钙治疗急性脑梗死病人的临床观察
3.
Methods 135 cases with acute progressive cerebral infarction were randomly divided into 3 groups :united group(n=45)that treated with Edaravone by intravenous infusion of 30mg(bid×14d)and low molecular weight heparin calcium hyodermic injection of 0.
方法将135例急性进展性脑梗死患者随机分为3组:治疗组45例,采用依达拉奉30mg+NS100ml静滴,30min滴完,每日2次,连用14天,同时低分子肝素钙0。
补充资料：肝素钙
分子式：暂无
分子量：暂无
CAS号：37270-89-6
性质：暂无
制备方法：暂无
用途：抗凝血药。
分子量：暂无
CAS号：37270-89-6
性质：暂无
制备方法：暂无
用途：抗凝血药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条